India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #1,233 Sanjay Bhatia & family ₹1,900 Cr
- #1,277 Ajay Bhatia & family ₹1,800 Cr
Revenue · FY 2025
₹1,553.39 Cr
▲ 18% YoY
Net profit · FY 2025
₹91.14 Cr
Net margin 5.9%
EBITDA · FY 2025
₹161.9 Cr
EBITDA margin 10.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.63 Cr
Issued & subscribed
Open charges
₹122.5 Cr
Satisfied ₹72.19 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
1,527
Provident fund records
About Laborate Pharmaceuticals India Ltd
Data last updated:
Laborate Pharmaceuticals India Ltd is a public limited company based in Panipat, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 March 1990 and has been in existence for over 36 years.
Its director Sanjay Bhatia and family are #1,233 among India's richest people (2026). Its director Ajay Bhatia and family are #1,277 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR1990PLC030835. Its GSTIN is 06AAACL2998K1Z3 (Haryana). The company holds 25 GST registrations, of which 22 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.63 Cr. It was formerly known as Laborate Pharmaceuticals India Pvt Ltd. It is led by directors including Sanjay Bhatia (Whole-Time Director) and Arpit Bhatia (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 11 Industrial Areapanipat, Haryana, India – 132103.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,553.39 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹91.14 Cr (net margin 5.9%) and EBITDA of ₹161.9 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 12% over five years.
The company has about 1,527 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Laborate Pharmaceuticals. As per MCA filings, the company has open charges of ₹122.5 Cr and satisfied charges of ₹72.19 Cr on record. Court records list 1,115 cases involving the company, including 1,011 filed by the company and 104 filed against it; 423 cases are pending. The company has 10 deals on record (9 secondary share transfers, 1 funding round), with disclosed funding of ₹87 Lakh; the latest was in March 2024.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website laborate.com.
Company details
CIN U24239HR1990PLC030835
Registration Number 030835
Incorporation Date 01 March 1990
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Sanjay Bhatia Whole-Time Director Arpit Bhatia Whole-Time Director Ajay Bhatia Whole-Time Director Recognitions & Rankings of Laborate Pharmaceuticals India
Contact details
Laborate Pharmaceuticals India Ltd's registered office is in Haryana, Haryana. Its website is laborate.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 11 Industrial Areapanipat, Haryana, India – 132103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Laborate Pharmaceuticals India Ltd, buy the company report.
Comprehensive company report
Laborate Pharmaceuticals India Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Laborate Pharmaceuticals India operates one associated brand: Laborate Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, laboratory testing, and research services in India. | laborate.com |
Financials of Laborate Pharmaceuticals India Ltd
FY 2025 filings availableLaborate Pharmaceuticals India Ltd reported revenue of ₹1,553.39 Cr (up 18% YoY) for FY 2025.
Revenue · FY 2025
₹1,553.39 Cr ▲ 18%
Net profit · FY 2025
₹91.14 Cr margin 5.9%
EBITDA · FY 2025
₹161.9 Cr margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 3%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▼ 9%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 18% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1,553.39 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹161.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹91.14 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Laborate Pharmaceuticals India Ltd, buy the company report.
Board of directors of Laborate Pharmaceuticals India Ltd
Laborate Pharmaceuticals India has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Bhatia | Whole-Time Director | 16 Apr 1990 | 36 Years 6 Months | Current |
| Sidharth Verma Also directs: Shamli Realties Private Limited | Director | 01 Oct 2018 | 8 Years 0 Months | Current |
| Arpit Bhatia Also directs: Aqualab India Private Limited | Whole-Time Director | 01 Aug 2021 | 5 Years 2 Months | Current |
| Garima Parashar Also directs: Aqualab India Private Limited | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Ajay Bhatia | Whole-Time Director | 16 Apr 1990 | 36 Years 6 Months | Current |
| Parag Bhatia Also directs: Aqualab India Private Limited | Whole-Time Director | 28 Jun 2014 | 12 Years 4 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Laborate Pharmaceuticals India Ltd is audited by VGCA & ASSOCIATES for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VGCA & ASSOCIATES | FY 2025 | 014283N |
Shareholding
The shareholding of Laborate Pharmaceuticals India Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Laborate Pharmaceuticals India Ltd, buy the company report.
Charges & borrowings
Open charges
₹122.5 Cr
Satisfied charges
₹72.19 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2026 | 101402975 | Hdfc Bank Limited | ₹4 Cr | Open | |
| 17 Sep 2025 | 101186139 | Axis Bank Limited | ₹1.5 Cr | Open | |
| 23 Jun 2005 | 80025558 | Others | ₹117 Cr | Open | |
| 17 Jan 2024 | 100863584 | Axis Bank Limited | ₹1 Cr | Satisfied | |
| 27 Jun 2018 | 100186138 | Others | ₹7.5 Cr | Satisfied |
To see the full charge records of Laborate Pharmaceuticals India Ltd, buy the company report.
Total charge records: 15 View all charges
Deals & funding
Laborate Pharmaceuticals India Ltd has 10 deals on record (9 secondary share transfers, 1 funding round), with disclosed funding of ₹87 Lakh; the latest was in March 2024.
Total deals
10
Secondary share transfers
9
Funding round
1
Disclosed funding
₹87 Lakh
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: Sanjeev Bhatia HUF, an individual |
| Mar 2023 | Secondary share transfer | Undisclosed | Seller: Sanjeev Bhatia HUF |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Sanjeev Bhatia HUF Seller: Aditya Bhatia Huf |
| Jan 2022 | Secondary share transfer | Undisclosed | Seller: Aditya Bhatia Huf, an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Aditya Bhatia Huf Seller: Sanjeev Bhatia HUF |
To see the full deal history of Laborate Pharmaceuticals India Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Laborate Pharmaceuticals India Ltd has 1,115 court cases on record: 1,011 filed by Laborate Pharmaceuticals India, 104 filed against it. 423 cases are pending and 692 are disposed.
Total cases
1,115
Filed by the company
1,011
Filed against the company
104
Pending
423
Disposed
692
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1,025 | 75 | 406 |
| High courts | 82 | 23 | 17 |
| Supreme Court | 7 | 5 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 1,115)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Finecure Pharmaceuticals Ltd | Pending |
| District court, Panipat, Haryana | Cheque dishonour complaint | Filed by the company against Irish Biotech OPC Private Limited | Pending |
| District court, South, Delhi | Commercial suit | Filed against the company by Cyber Media Research and Services Limited | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company | Pending |
| District court, Bikaner, Rajasthan | Criminal case | Filed against the company by State | Pending |
To see the full case history of Laborate Pharmaceuticals India Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Laborate Pharmaceuticals India Ltd was last rated by Icra on 07 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 07 Oct 2021 |
To see the full credit ratings and regulatory alerts of Laborate Pharmaceuticals India Ltd, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Laborate Pharmaceuticals India Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Laborate Pharmaceuticals India Ltd has a workforce of 1,527 employees on its EPFO records as of Feb 25, 2026, across 2 active EPFO establishments.
Employee count
1,527
Active EPFO establishments
2
Employee growth
3.67%
GST
Laborate Pharmaceuticals India has 25 GST registrations: 22 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
25
Active
22
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACL2998K1Z3 | Haryana | Active | 01 Jul 2017 |
| 06AAACL2998K3Z1 | Haryana | Active | 01 Mar 2025 |
| 02AAACL2998K1ZB | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACL2998K1Z9 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Laborate Pharmaceuticals India Ltd, buy the company report.
Recent activity
Laborate Pharmaceuticals India Ltd has 15 board changes on record since 1990: 7 appointments and 8 cessations. The latest: Sanjay Kundu was appointed as Director on 22 May 2025.
Charges
A charge with Others of Rs. 117.00 Cr registered on 23 Jun 2005 with Charge ID 80025558 was modified on 15 Sep 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.00 Cr with Charge ID 101402975 was registered on 07 Sep 2026.
AGM
Laborate Pharmaceuticals India Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.50 Cr with Charge ID 101186139 was registered on 17 Sep 2025.
Charges
A charge registered on 17 Jan 2024 via Charge ID 100863584 with Axis Bank Limited was fully satisfied on 07 Jul 2025.
Appointed
Sanjay Kundu was appointed as Director.
Filing
Laborate Pharmaceuticals India Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Pankaj Mutneja ceased to be Director.
Ceased
Anita Bhatia ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100863584 was registered on 17 Jan 2024.
Ceased
Garima Parashar ceased to be Additional Director.
Appointed
Arpit Bhatia was appointed as Whole-Time Director.
38 earlier events are in the company report.
Frequently asked questions
Laborate Pharmaceuticals India is an active public limited company based in Panipat, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 March 1990 (36+ years old) and is registered under CIN U24239HR1990PLC030835.
Laborate Pharmaceuticals India has 7 current directors:
- Sanjay Bhatia - Whole-Time Director
- Arpit Bhatia - Whole-Time Director
- Ajay Bhatia - Whole-Time Director
- Parag Bhatia - Whole-Time Director
- Sidharth Verma - Director
- Garima Parashar - Director
- Sanjay Kundu - Director
The latest financial statements of Laborate Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Laborate Pharmaceuticals India is 06AAACL2998K1Z3, registered in Haryana. The company has 25 GST registrations in all, of which 22 are active and 3 are cancelled or inactive. Other active GSTINs include 06AAACL2998K3Z1 (Haryana), 02AAACL2998K1ZB (Himachal Pradesh), 03AAACL2998K1Z9 (Punjab).
The CIN (Corporate Identification Number) of Laborate Pharmaceuticals India is U24239HR1990PLC030835. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laborate Pharmaceuticals India has 1,115 court cases on record: 1,011 filed by the company and 104 filed against it. 423 are pending. Most are in the district courts.
Laborate Pharmaceuticals India was incorporated on 01 March 1990, making it 36+ years old. It is registered with the Registrar of Companies, Haryana.
Laborate Pharmaceuticals India has 10 deals on record (9 secondary share transfers, 1 funding round), with disclosed funding of ₹87 Lakh; the latest was in March 2024.
Sanjay Kundu was appointed as Director on 22 May 2025. Pankaj Mutneja ceased to be Director on 28 Feb 2025. Anita Bhatia ceased to be Director on 21 Mar 2024. Laborate Pharmaceuticals India has 15 board changes on record in total.
Laborate Pharmaceuticals India can be reached through the website laborate.com. Its registered office is in Panipat, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages